SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Enhancing Industrial Cultivation: A Breakthrough Approach Using Methylated Compounds to Expedite Microbial Growth

This project aims to reduce microbial cultivation costs by shortening the lag phase using methylated compounds, potentially revolutionizing the industry and enhancing product yield.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

Industries reliant on microbial cultivation face high production costs, with the cultivation process accounting for 20-40% of the total. However, conventional strategies often overlook the lag phase, an early growth phase in which bacteria do not grow, that significantly elongates the cultivation process and impacts production costs.

Recent Findings

Recent findings arising from our ERC-funded research reveal a ground-breaking mechanism for modulating bacterial lag phase duration. Through the addition of naturally abundant methylated compounds during the lag phase, we demonstrate a strategy to expedite bacterial growth by up to 10 hours. This approach, previously unexplored due to technical challenges, could revolutionize industrial cultivation, reducing costs and enhancing product yield.

Novel Regulatory Circuit

Our ERC-funded research uncovered a novel regulatory circuit influencing the bacterial lag phase. In our research of algal-bacterial routes of metabolic exchange, we discovered that abundant methylated compounds produced by algae and plants can significantly expedite the lag phase of various bacteria.

Mechanism Insights

Detailed insights into this mechanism enabled tailored treatments that shorten lag phases by utilizing methylated compounds. This approach presents a safe, affordable, and unique solution for industry challenges.

Proposal Overview

In this proposal, we outline a comprehensive plan to address current industrial cultivation challenges and exploit our innovative approach. By leveraging methylated compounds to expedite lag phases, both in bacteria and yeast, we aim to:

  1. Optimize yield
  2. Revolutionize microbial cultivation
  3. Potentially transform an industry with an expected value of $130-180 billion by 2030

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-7-2024
Einddatum31-12-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • WEIZMANN INSTITUTE OF SCIENCEpenvoerder

Land(en)

Israel

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Translating a new metabolic engineering strategy to industrial biotech applications

The TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production.

ERC Proof of...€ 150.000
2023
Details

Scalable Microbial Metabolite Discovery Through Synthetic Biology

This project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development.

ERC Starting...€ 1.490.250
2024
Details

Microbial Synthetic in vivo Cell Therapy Systems

The MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways.

ERC Starting...€ 1.499.938
2023
Details

Flux Race Investigation for Dissection Of Metabolic-bottlenecks: Leveraging the tremendous potential of algal metabolic diversity

This project aims to identify metabolic bottlenecks in photosynthetic cells using advanced flux analyses to enhance crop yields and meet future food production demands sustainably.

ERC Starting...€ 1.937.500
2023
Details

Production of a second phase of hydrophobic aromatics with solvent-tolerant Pseudomonas

The PROSPER project aims to engineer solvent-tolerant Pseudomonas for efficient microbial production of hydrophobic aromatic chemicals, overcoming toxicity barriers for sustainable biotechnological applications.

ERC Consolid...€ 1.999.485
2023
Details
ERC Proof of...

Translating a new metabolic engineering strategy to industrial biotech applications

The TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Starting...

Scalable Microbial Metabolite Discovery Through Synthetic Biology

This project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development.

ERC Starting Grant
€ 1.490.250
2024
Details
ERC Starting...

Microbial Synthetic in vivo Cell Therapy Systems

The MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways.

ERC Starting Grant
€ 1.499.938
2023
Details
ERC Starting...

Flux Race Investigation for Dissection Of Metabolic-bottlenecks: Leveraging the tremendous potential of algal metabolic diversity

This project aims to identify metabolic bottlenecks in photosynthetic cells using advanced flux analyses to enhance crop yields and meet future food production demands sustainably.

ERC Starting Grant
€ 1.937.500
2023
Details
ERC Consolid...

Production of a second phase of hydrophobic aromatics with solvent-tolerant Pseudomonas

The PROSPER project aims to engineer solvent-tolerant Pseudomonas for efficient microbial production of hydrophobic aromatic chemicals, overcoming toxicity barriers for sustainable biotechnological applications.

ERC Consolidator Grant
€ 1.999.485
2023
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Biosensor Activated Biomanufacturing Scale-up

Enduro aims to revolutionize microbial biomanufacturing with its synthetic biology plugin, Enduro Sense, to enable scalable processes and attract investment for commercial deployment.

EIC Accelerator€ 1.815.295
2023
Details

TUNGSTEN BIOCATALYSIS – HEAVY METAL ENZYMES FOR SUSTAINABLE INDUSTRIAL BIOCATALYSIS

This project aims to develop a new W-cofactor biosynthesis pathway in E. coli to produce tungsten-containing enzymes for sustainable chemical processes, enabling efficient CO2 reduction and cosmetic ingredient production.

EIC Pathfinder€ 2.430.574
2024
Details

Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections

LeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations.

EIC Pathfinder€ 2.665.564
2022
Details

Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues

The MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026.

EIC Accelerator€ 2.441.250
2024
Details
EIC Accelerator

Biosensor Activated Biomanufacturing Scale-up

Enduro aims to revolutionize microbial biomanufacturing with its synthetic biology plugin, Enduro Sense, to enable scalable processes and attract investment for commercial deployment.

EIC Accelerator
€ 1.815.295
2023
Details
EIC Pathfinder

TUNGSTEN BIOCATALYSIS – HEAVY METAL ENZYMES FOR SUSTAINABLE INDUSTRIAL BIOCATALYSIS

This project aims to develop a new W-cofactor biosynthesis pathway in E. coli to produce tungsten-containing enzymes for sustainable chemical processes, enabling efficient CO2 reduction and cosmetic ingredient production.

EIC Pathfinder
€ 2.430.574
2024
Details
EIC Pathfinder

Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections

LeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations.

EIC Pathfinder
€ 2.665.564
2022
Details
EIC Accelerator

Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues

The MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026.

EIC Accelerator
€ 2.441.250
2024
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.